BioNTech SE Research and Development Expense
BioNTech SE (BNTX) reported Research and Development Expense of EUR 2.10 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-10
| Period end | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | 2.10B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 2.25B EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 1.78B EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 1.54B EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 949.20M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 645.00M EUR 20-F · filed 2023-03-27 | 645.03M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 226.50M EUR 20-F/A · filed 2022-10-26 | 226.47M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 143.04M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | 85.50M EUR 20-F · filed 2020-03-31 |